GLP-1 and obesity drug stocks
Companies that sell or are developing GLP-1 drugs and other medicines for obesity, like the ones sold as Ozempic, Wegovy, Mounjaro, and Zepbound. Trial results, FDA decisions, and prices drive the news.
Highest Quality Scores
The other 11, by name
Open any stock for its score. Pro members see every stock ranked.
Here is what Pro members see.
Every theme has a page like this for Pro members, GLP-1 and obesity drug stocks included: each stock ranked live by its Quality Score, with the reason it belongs.




- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
What moved today
Today, as of 8:46 PM ET, GLP-1 and obesity drug stocks are down 1.8% on average, 13 of 14 down. MBX Biosciences (MBX) rose most, up 3.5%. Kailera Therapeutics (KLRA) fell most, down 5.8%.
What moves GLP-1 and obesity drug stocks
- Trial results and FDA decisions
- Prices, and whether Medicare and insurers pay
- Prescription numbers each quarter
What are GLP-1 and obesity drug stocks?
Companies that sell or are developing GLP-1 drugs and other medicines for obesity, like the ones sold as Ozempic, Wegovy, Mounjaro, and Zepbound. Trial results, FDA decisions, and prices drive the news.
How many GLP-1 and obesity drug stocks are there?
This list has 14, the ones among the stocks Breakaway scores where the theme is the main business. Device makers whose parts go into the pens, supplement sellers, and companies whose obesity program is a minor one.
Which GLP-1 and obesity drug stocks have the highest Quality Score?
As of 8:46 PM ET: Amgen (AMGN) 11, Eli Lilly (LLY) 10, and Hims & Hers Health (HIMS) 2. Each stock's own page shows its score and the reasons behind it.
How this list is made
It sells or is developing a GLP-1 drug or another obesity medicine, or sells GLP-1 prescriptions as a main line, and its annual report says so. Each company is checked against its own annual report, and the reason beside it says what it does in this theme. Last checked Oct 2 2026.
Drug developers' FDA dates are on the FDA calendar. More in healthcare stocks, or every theme.
Every one of the 14, ranked.
Real-time prices, each stock's Quality Score, the theme's score over 60 sessions, every date ahead, the filing behind each company, and optional alerts.
Free for 24 hours. No account needed. Then keep going with a free account.